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Abstract
Purpose: Iron deposition has been shown to occur following myocardial infarction (MI). We investigated whether such focal
iron deposition within chronic MI lead to electrical anomalies.
Methods: Two groups of dogs (ex-vivo (n = 12) and in-vivo (n = 10)) were studied at 16 weeks post MI. Hearts of animals
from ex-vivo group were explanted and sectioned into infarcted and non-infarcted segments. Impedance spectroscopy was
used to derive electrical permittivity (e) and conductivity (s). Mass spectrometry was used to classify and characterize tissue
sections with (IRON+) and without (IRON-) iron. Animals from in-vivo group underwent cardiac magnetic resonance imaging
(CMR) for estimation of scar volume (late-gadolinium enhancement, LGE) and iron deposition (T2*) relative to left-ventricular
volume. 24-hour electrocardiogram recordings were obtained and used to examine Heart Rate (HR), QT interval (QT), QT
corrected for HR (QTc) and QTc dispersion (QTcd). In a fraction of these animals (n = 5), ultra-high resolution
electroanatomical mapping (EAM) was performed, co-registered with LGE and T2* CMR and were used to characterize
the spatial locations of isolated late potentials (ILPs).
Results: Compared to IRON- sections, IRON+ sections had highere, but no difference ins. A linear relationship was found
between iron content and e (p,0.001), but not s (p = 0.34). Among two groups of animals (Iron (,1.5%) and Iron (.1.5%))
with similar scar volumes (7.28%61.02% (Iron (,1.5%)) vs 8.35%62.98% (Iron (.1.5%)), p = 0.51) but markedly different iron
volumes (1.12%60.64% (Iron (,1.5%)) vs 2.47%60.64% (Iron (.1.5%)), p = 0.02), QT and QTc were elevated and QTcd was
decreased in the group with the higher iron volume during the day, night and 24-hour period (p,0.05). EAMs co-registered
with CMR images showed a greater tendency for ILPs to emerge from scar regions with iron versus without iron.
Conclusion: The electrical behavior of infarcted hearts with iron appears to be different from those without iron. Iron within
infarcted zones may evolve as an arrhythmogenic substrate in the post MI period.
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Introduction
The electrical behavior of chronically infarcted myocardium is
not well understood. Conventionally, infarcted myocardium is
identified on electroanatmoical maps (EAMs) on the basis of
significantly reduced bipolar voltage (below 0.5 mv) [1,2]. While a
significant portion of the scarred myocardium is thought to be
electrically inert, the presence of non-zero voltage points within
the infarct zone has been associated with surviving myocytes [3,4].
However, several other studies have shown direct evidence for
significant passive electrical activity within the dense scar that is
free of viable myocytes [5,6]. Nevertheless, the substrate mediating
the electrical activity within the infarcted tissue devoid of surviving
myocyte bundles remains to be explored.
Observational studies in patients with pathological iron (hemo-
siderin) overloading in the heart, from non-ischemic origins
(hemochromatosis [7,8], thalassemia [9,10], siderosis [11], and
sickle-cell anemia [12]), have long documented evidence of
significant incidence of ventricular arrhythmias [13–16]. Imaging
studies in the same patient population have also suggested that the
incidence of arrhythmias to be directly related to the extent of
myocardial iron deposition [16]. Moreover, carefully controlled
animal studies have shown that cardiac iron overloading leads to
progressively worsening electrical conductivity with increasing iron
(hemosiderin) deposition, even in the absence of myocardial
contractility changes [14]. Notably, these studies showed that
approximately 1 in 3 animals with chronic iron overloading
succumbed to sudden cardiac death (SCD) attributable to cardiac
arrhythmias. More recently, magnetic resonance imaging based
histological examination of human hearts of SCD victims have
shown significant loss of T2-weighted signals within the chronic
infarcted territories, consistent with hemosiderin accumulation
[17,18].
The relationship between myocardial iron deposition and
electrical changes may be explored on the basis of existing
biophysical findings. It has been shown that the introduction of
highly conductive particulates (such as magnetite with conductivity
of 2.56104 S/m at the physiologic temperature) [19] into an
otherwise poor dielectric medium (such as the myocardium with
conductivity ,1 S/m) [20] acts to enhance the bulk electrical
permittivity of the medium [21,22]. Hence, the pathological
elevations of iron within localized regions of the heart may be a
substrate that alters the electrical milieu of myocardial regions
containing iron.
Recent studies in humans and animals have demonstrated that
chronic iron (hemosiderin) overloading within the scar tissue may
occur following myocardial infarctions due to pooling of blood
within the infarcted territories [23]. Based on biophysical
principles alone, it is expected that the electrical permittivity of
post-infarction scar with iron deposits can be significantly greater
than those scars without iron deposits. If such changes in the
electrical features of the infarcted myocardium manifest in the
same manner as in the case of iron overloading from the non-
ischemic pathologies, one is expected to observe global and local
electrical changes that are different between infarcted hearts with
and without iron depositions.
Through controlled experiments in a canine model, this study
investigates whether infarcts with chronic iron deposition,
identified on the basis of mass spectrometry, preferentially alters
the electrical features of myocardial tissue in ex-vivo preparations.
In addition, it also examines whether there are differences in
global and local electrical characteristics of the infarcted hearts
with different levels of iron deposition, determined on the basis of
cardiac magnetic resonance imaging (CMR). In particular, this
study explores whether the established parameters derived from
surface electrocardiograms (ECG) and EAMs are altered in a
manner that is dependent on the extent of iron deposition.
Methods
Ethics Statement
Mongrel dogs were studied according to the protocols approved
by the Animal Care and Use Committee of Northwestern
University (IACUC number: 2007–1286) and Cedars-Sinai
Medical Center (IACUC number: 0003674). The Animal Care
and Use Committee of Northwestern University and Cedars-Sinai
Medical Center approved the studies described below.
Animal Preparation and Overview of Methods
Myocardial infarction (MI) was created by permanently ligating
the left anterior descending (LAD) artery distal to the first diagonal
in 22 dogs (20–25 kg), and allowed to recover for 16 weeks. In the
first group (Group ex-vivo, n = 12), 10 animals survived into the
chronic phase of the infarction and 2 animals died during the
acute phase of MI. Animals from Group ex-vivo were sacrificed and
their hearts were harvested, and sectioned into 1 cm thick slices.
Figure 1. Schematic three-dimensional drawing of a custom-
made capacitor cell used for measuring bulk electrical
impedance of ex-vivo tissue. The capacitor cell consisted of a
transparent tubular glycol-modified polyethylene teraphthalate (PETG)
body that is closed at one end and fitted with a removable Delrin cap at
the other end. Two square silver electrodes, each of 1.5 cm2 surface
area, were enclosed in the tubular body. One electrode was affixed to
the closed end, while the other electrode was affixed to a PETG disk
that can move through the tubular body. The electrodes were soldered
to the inner conductors of copper coaxial cables, which in turn were
connected to the impedance analyzer. The outer conductors were
connected to electrical ground.
doi:10.1371/journal.pone.0073193.g001
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Infarcted and non-infarcted (Remote) segments on each slice were
delineated on the basis of ex vivo triphenyl tetrazolium chloride
(TTC) staining [24], and 0.5–0.8 cm3 samples of tissue were
isolated from the respective segments. Representative samples
were selected for histological staining (Perl’s stain). Samples from
infarcted segments were further classified as those with and
without iron deposition (IRON+ and IRON2 respectively) based
on mass spectrometric analysis (details below). Prior to mass
spectrometric analysis, bulk electrical impedance spectroscopy
measurements were performed on tissue samples from all the three
groups (IRON+, IRON2 and Remote).
The animals from Group in-vivo were fitted with a Holter
monitor and ECG measurements were recorded over a 24-hour
period (details below). Subsequently the animals from this group
underwent CMR studies (within a week of the ECG recordings) to
determine the extent of iron deposition within the myocardial
infarct territories (details below). Following CMR exams, 5
animals from this group underwent ultra-high resolution endo-
cardial left ventricular electroanatomical mapping (EAM, details
below).
Ex vivo Bulk Electrical Impedance Measurements
The bulk electrical impedance of each tissue sample was
measured using the two-terminal electrode technique as previously
described by Schwan [25]. A capacitor cell consisting of two
parallel square electrodes (each of 1.5 cm2 surface area) with
variable distance between them [26] was custom built to measure
bulk electrical impedance of each sample using alternating-current
(AC) impedance spectroscopy (Fig. 1).
Each sample was incubated at 37uC in phosphate buffer
solution for 15 minutes prior to use. The sample was then
sandwiched between the two electrodes of the capacitor cell and
10 mA of alternating current was passed parallel to the myocardial
fibers. The voltage that developed across the sample was measured
using Solartron 1260 impedance/gain-phase analyzer (Solartron
Instruments, Hampshire, UK) and acquired using ZPlot data
acquisition software (version 3.3, Scribner Associates Inc., NC,
USA). The complex AC-impedance (Z in ohms) of the sample was
estimated as a quotient of the induced voltage and the current
supplied to the sample. The impedance values were measured at
frequencies ranging from 100 Hz to 10 MHz with 10 measure-
ments in each frequency decade. Stray effects in the measurements
were corrected using methods described by Schwan [25]. To
minimize the effects of a-dispersion at lower frequencies (below
0.1 MHz) and b-dispersion (above 1 MHz) [27] from undesirable
myocardial sample preparation errors (such as, partial volume
effects from samples containing both infarcted tissue and
surrounding viable myocardium), all analyses were limited to
impedance data acquired at 1 MHz. Based on the impedance
measurements, electrical permittivity and conductivity were
estimated as previously described [28]. Refer to File S1.
For a given heart from an infarcted dog, mean conductivity
(s0Remote) and permittivity (e
0
Remote) of its remote myocardium were
calculated by weight-averaging the conductivities and permittiv-









where, sRemoteand eRemoteare the individual conductivity and
permittivity of each constituent remote sample of a heart and
Figure 2. Representative specific impedance spectra from
Remote, IRON-, and IRON+ myocardial samples. Note that for a
given AC frequency, the specific impedance of IRON+ samples is higher
than that of the Remote and IRON2 samples.
doi:10.1371/journal.pone.0073193.g002
Figure 3. Electrical consequences of iron deposition in ex-vivo myocardium. (A) Mean e measured from Remote, IRON2, and IRON+ infarct
sections showed significantly greater e (*, p,0.001) in IRON+ compared to Remote and IRON2 sections; (B) however, mean s measured from
Remote, IRON2, and IRON+ infarct sections did not show any statistical difference in s between the different sections.
doi:10.1371/journal.pone.0073193.g003
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WRemote is its corresponding sample weight. Normalized conduc-
tivity (ssample) and permittivity (esample) of each IRON+, IRON2







Also, per-slice normalized conductivity (sslice) and permittivity
(eslice) were calculated for the IRON+, IRON2, and Remote
groups by weight averaging ssample and esample respectively from
their constituent samples.
Inductively Coupled Plasma – Mass Spectrometry (ICP-
MS)
Iron deposition within each myocardial sample from Group ex-
vivo ([Fe]sample in mg per g of tissue) was measured using a
quadrupole-based X Series 2 ICP-MS (Thermo-Fisher Scientific,
USA). Infarcted sections with [Fe]sample ,0.05 mg/g [23] of tissue
were labeled as IRON2 and those with [Fe]sample $0.05 mg/g
were labeled as IRON+. In all, 293 sections from a total of 11 dogs
were analyzed, where 228 sections were infarcted and 67 sections
were non-infarcted.
Holter ECG Recordings and Surface ECG Analysis
24-hour Holter ECG recordings were made 16 weeks post MI
in animals from Group in-vivo (n = 10) using a three-channel
recorder (DigiTrak XT Holter Recorder, Philips Zymed Holter
System, Philips Healthcare, MA, USA). Protective bandages and
custom-made jackets were used to secure the Holter over the
animals. The derived 12-lead ECG was recorded continuously
using five adhesive leads placed (a) over the lower sternum, level
with the fifth intercostal space; (b) at the level of the fifth intercostal
space, on the left midaxillary line; (c) on the upper part of the
sternum; (d) at the fifth intercostal space, on the right midaxillary
line; and (e) on the manubrium of the sternum (reference/ground
electrode).
All ECG recordings underwent automated retrospective anal-
ysis using the dedicated Holter software (DigiTrak XT Holter
Recorder, Philips Zymed Holter System Philips Healthcare, MA,
USA). The analysis of heart rate (HR) and repolarization
parameters (QT, QTc) was performed after adjusting all
recordings to the 24-hour clock. Only recordings with duration
of 24 hours were considered for analysis. An operator blinded to
the MR details of the infarct characteristics analyzed the Holter
recordings. The morphology of the beats was monitored and only
normal beats (sinus rhythm) were selected for further analysis.
ECG segments with excessive noise or artifact were eliminated
from the analysis. The hourly mean values of each measurement
were automatically calculated. QT intervals corrected for heart
rate (QTc) were automatically calculated using Bazett’s formula
[29]. QTc dispersion (QTcd) was computed as the difference
between the maximum and the minimum QTc interval across the
12 derived leads.
CMR Exam and Image Analysis
Prior to imaging, canines were fasted for 18 hours, sedated,
anesthetized, intubated, transferred to the scanner table and were
connected to a ventilator for mechanical ventilation. Animals were
maintained on gas anesthesia (2–2.5% isoflurane and 100%
oxygen). CMR studies were performed on a clinical 3T system
(MAGNETOM Verio, Siemens Medical Solutions, Erlangen,
Germany) within one week of ECG recordings being taken. Multi-
gradient echo T2*-weighted (TR =12 ms, 6 TEs = 2.0 ms –
9.5 ms with DTE =1.5 ms, flip angle = 10u and BW =930 Hz/
pixel) and late-gadolinium enhancement (LGE) images (inversion-
recovery prepared FLASH, TR / TE =3.0/1.5 ms, flip angle
= 25u and BW =586 Hz/pixel) of contiguous short-axis sections
covering the entire left ventricle (LV) and the three long-axis views
were acquired at mid-diastole. Commonly used imaging param-
eters were: in-plane resolution = 1.361.3 mm2, slice thickness
= 6 mm and number of averages = 1.
Image analyses were performed using cmr42 (v4.0, Circle
Cardiovascular Imaging Inc., Canada). Remote myocardium was
defined as the region showing no hyperintensity on LGE images. A
reference region-of-interest (ROI) was drawn in the remote
myocardium on both LGE and T2*-weighted images. Infarcted
territory was defined as the hyperintense region on LGE images
with mean signal intensity (SI) of at least 5 standard deviations
(SD) above that of the reference ROI [30]. An infarction with
Table 1. Relationship between Normalized Permittivity and Iron Content.
Normalized
Conductivity Coefficient Standard Error Z P.Z Lower 95% CI Upper 95% CI
[Fe] in mg/g of tissue 0.23 0.24 0.96 0.337 20.24 0.71
Constant 0.86 0.09 9.97 ,0.001 0.69 1.02
doi:10.1371/journal.pone.0073193.t001
Table 2. Relationship between Normalized Permitivity and Iron Content.
Normalized
Permittivity Coefficient Standard Error Z P.Z Lower 95% CI Upper 95% CI
[Fe] in mg/g of tissue 1.34 0.31 4.33 ,0.001 0.73 1.95
Constant 0.94 0.10 9.30 ,0.001 0.74 1.13
doi:10.1371/journal.pone.0073193.t002
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chronic iron deposition (IRON+) was defined as infarcted territory
containing hypointense signal on the T2*-weighted image
acquired at TE of 6.5 ms with mean SI of at least 2SDs below
that of the reference ROI [31,32]. An infarction without iron
deposition (IRON2) was defined as the region positive for
infarction on LGE images, but negative for hypointense signal on
the corresponding T2*-weighted images. The percentage of the
infarcted myocardium (Scar Volume) and myocardium with chronic
iron deposition (Iron Volume) were computed by summing up the
respective slice measures and normalizing by the total left-
ventricular volume.
Electroanatomical Mapping, Analysis and Registration
with CMR Images
Electrophysiological studies were performed within 3–7 days of
the CMR studies in 5 animals under general anesthesia and
mechanical ventilation (protocol same as during CMR). The left
femoral artery was cannulated, and a 64-electrode basket catheter
(nominal diameter 18 mm) with 8 splines, each containing 8 tiny
electrodes (0.4 mm2) spaced at 2.5 mm, center-to-center (Rhyth-
mia Mapping System, Boston Scientific, MA, USA) was
introduced into the left ventricle using the retro-transaortic
approach. The catheter was used to generate ultra-high resolution
endocardial contact electrograms (EGMs; within 2–3 mm spatial
resolution). The surface geometry was mapped using the location
of the outermost electrodes. Only EGMs recorded within 2 mm of
the surface geometry were utilized. Scar areas were defined as
bipolar voltage less than 1 mV [33].
At least three clinical electrophysiology experts analyzed the
EAMs from each animal offline. Given the large number of data
points within and surrounding the scarred myocardium, only
points separated by 1.5–2 mm of one another were manually
validated. The validation process included ensuring catheter
contact and identifying and marking each point of interest for
the presence or absence of isolated late potentials (ILPs). An ILP
was defined as a voltage spike following an isoelectric interval
observed after the end of the QRS complex [34–36].
The LGE and T2* CMR data were registered with the EAMs
using a custom-developed software. The registration process
involved (a) manually segmenting the blood pool of both LGE
and T2* images; (b) constructing a surface that encloses the
segmented blood pool; and (c) manually registering both the LGE
and T2* blood pool surface to the EAM surface using anatomical
landmarks (apex, papillary muscle grooves and aortic root). The
gray scale CMR data was resampled at the vertices of the CMR
blood pool mesh and displayed as a colored 3D surface with colors
corresponding to signal intensity.
Figure 4. Relation between scar features and chronic iron deposition. (A) Representative short-axis LGE and T2*-weighted (TE = 6.5 ms)
images from two canines subjected to MI from Group in vivo – one with chronic iron deposition within the scar territory (Iron (.1.5%)) and another
without chronic iron deposition (Iron (,1.5%)) are shown. Red arrows point to the site of myocardial scar on the LGE images in both the cases and to
chronic iron deposition on the T2*-weighted image. (B) A significant sigmoidal relation was found between scar volume and iron volume (both
computed as a percentage of total LV myocardium; R2 = 0.75, p ,0.001).
doi:10.1371/journal.pone.0073193.g004
Figure 5. Histological Findings. The presence of infarction apparent on TTC staining (A) and iron (B, blue Perl’s stains; black arrows) within
chronic MI and its absence (C, Perl’s stain) in remote sections are shown. Note that the iron deposits are typically found in the interstitial/extracellular
space. The blue and red boxes within the TTC images correspond to the histology sections from infarcted and remote (non-infarcted) regions.
doi:10.1371/journal.pone.0073193.g005
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After registration with the EAMs, the T2* blood pool mesh was
used to manually count the number of ILPs occurring in and
around the infarcted regions with and without iron. This
information was used to derive values for the overall incidence
of ILPs, which were computed as a percentage of ILPs from
regions with and without iron relative to the total number of ILPs
in the infarct territory. To examine the relationship between the
number of ILPs and substrate type and extent, values normalized
by the volume fraction of substrate type in each heart were
computed and averaged across all animals. In particular, the
following calculations were performed: (a) ILP counts from regions
with iron normalized by Iron Volume; (b) ILP counts from regions
without iron normalized by the percentage scar volume without
iron (i.e. Scar Volume – Iron Volume); and (c) the total ILP count
normalized by the percentage of total scar volume (with and
without iron) relative to the total volume of myocardium.
From the EAMs registered with T2* images, number of ILPs
occurring in and around the infarcted regions with and without
iron were manually counted. This information was used to derive
the overall incidence of ILPs, which was computed as a percentage
of ILPs from regions with and without iron relative to the total
number of ILPs. To examine the relationship between number of
ILPs and substrate type and extent, values normalized by the
volume fraction of substrate type in each heart were computed and
averaged across all animals. In particular, the following calcula-
tions were performed: (a) ILP counts from regions with iron
normalized by Iron Volume; (b) ILP counts from regions without
iron normalized by percentage scar without iron (i.e. Scar Volume –
Iron Volume); and (c) the total ILP count normalized by Scar Volume
(i.e. myocardial volume normalized scars with and without iron).
Statistical Analysis
All statistical analyses were performed using SPSS (IBM SPPS
Statistics v21.0, New York, NY, USA). A p value ,0.05 was
considered statistically significant. Bonferroni correction was used
to adjust the significance level for multiple comparisons. Data
normality was assessed using the Shapiro-Wilk test and quantile-
quantile plots. Student’s t-test or mixed-model ANOVA with
Tukey’s post-hoc analysis was used to compare data with normal
distributions. For the mixed model, animals were entered as
random effects, while repeated measurements from the same
animal or heart were entered as fixed effects. Repeated
measurements from a single animal or heart were nested. For
comparing non-normal data, non-parametric Friedman’s test was
used. Mann-Whitney U test was used for pairwise comparisons
among non-normal data.
For the canines from Group ex vivo, ssample and esample were
compared among IRON+, IRON2, and Remote tissue sections.
Mixed-model linear regressions was used to evaluate the
Figure 6. Mean values of important surface ECG parameters over day, night and a 24-hour period from Iron (.1.5%) and Iron
(,1.5%) dogs. The mean values from dogs with and without iron over the period of interest for heart rate (A), QT (B), QTc (C) and QTcd (D) are
shown.
doi:10.1371/journal.pone.0073193.g006
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relationships of ssample and esample with [Fe]sample. A nonlinear
regression analysis was used to examine the relationship between
Iron Volume and Scar Volume.
In order to examine the effect of Iron Volume on the ECG
parameters (HR, QT, QTc and QTcd) with minimal/no
contribution from Scar Volume, animals were divided into two
groups, those with Iron Volume ,1.5% (denoted as Iron (,1.5%))
and those with Iron Volume.1.5% (denoted as Iron (.1.5%)). Only
those animals that showed a direct relationship between Iron
Volume and Scar Volume were included in the analysis (details below).
Mean hourly, day (10:00 hrs to 21:00 hrs), night (21:00 hrs to
09:00 hrs) and 24-hour measurements of HR, QT, QTc, and
QTcd were computed for Iron (,1.5%) and Iron (.1.5%) groups
and compared, as above.
Regression analysis was used to assess the quality of the
registration between CMR and EAMs on the basis of concordance
between scar territories identified on LGE CMR and low voltage
(,1 mV) vertices on bipolar EAMs. The incidence of ILPs was
compared between scar regions with iron and without iron. The
number of ILPs per volume of substrate for scars with only iron
and without iron was also compared.
Results
Effect of Iron Deposition on the Ex-vivo Electrical
Capacitance of Myocardial Infarcts
Of 228 infarcted sections, mass spectrometry analysis identified
177 sections as IRON+ and the remaining 51 sections as IRON2.
There was no significant difference in [Fe]sample between IRON2
and Remote samples (p = 0.31). A set of sample impedance spectra
from IRON+, IRON2, and Remote sections from an animal are
shown in Fig. 2. Mean esample for IRON+ sections was significantly
different from mean esample for IRON2 and Remote tissues
(p,0.001), while esampleof IRON2 and Remote sections were not
statistically different from 1 (p= 0.69; Fig. 3A). Mean ssample was
not significantly different among the different tissue types (Remote
vs IRON+: p = 0.46; Remote vs IRON2: p = 0.77; Fig. 3B).
Averaged across all studies, a mean increase in esample of
approximately 25% in the infarcted territories with iron deposition
was observed, while no change was observed in remote or
infarcted territories without iron. Mixed-effects multi-linear
regression analysis showed a statistically significant relation
between esample and [Fe]sample (esample =1.34 [Fe]sample +0.93;
p,0.001; Table 1), but not between ssample and [Fe]sample (p = 0.34;
Table 2).
Figure 7. 24-hour Holter ECG recordings from Iron (.1.5%) and Iron (,1.5%) dogs. The mean 24-hour traces showing changes in heart
rate (A), QT (B), QT corrected for heart rate (C), and QTc dispersion (D) are shown for the two different groups of dogs with and without iron
deposition.
doi:10.1371/journal.pone.0073193.g007
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Figure 8. Representative co-registered CMR images and endocardial EAMs showing the association between ILPs and iron
deposition following myocardial infarction. Co-registered late-gadolinium enhancement images projected onto the segmented blood pool
surface (A) with infarcted territory (color coded in red), border zone (yellow and blue shades) and remote territories (purple)) with the corresponding
bipolar map (B, color-coded to indicate low voltage areas) are shown. For reference, an ILP deep within the scar tissue (white arrow) is shown. The
voltage traces from V1 and at the coronary sinus (CS), along with bipolar and unipolar mapping traces are also shown. Note the presence of an
isolated low-voltage sharp late potential in the bipolar and unipolar traces following the local ventricular activation (yellow arrow) in C. The activation
map (D), a map of the ILPs (E), and iron containing regions (in red, F) are also shown for reference. Note that iron-containing regions have a greater
incidence of ILPs and slow activation regions.
doi:10.1371/journal.pone.0073193.g008
Figure 9. Dependence on the probability of observing ILPs based on substrate type and number of ILPS relative to substrate
burden visualized on the basis of co-registered EAM and CMR images (LGE and T2*). (A) Shows the overall incidence of ILPs (fraction of
the total) that were coincident with regions containing iron (IRON+) and regions without iron (IRON2). (B) Shows the mean number of ILPs per
volume of substrate, with the substrate being the total scar (i.e., scar with and without iron), scarred regions with iron (IRON+) and scarred regions
without iron (IRON2).
doi:10.1371/journal.pone.0073193.g009
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In-vivo Studies
All 10 animals were positive for infarction and survived the
CMR study. CMR studies showed iron depositions to be within
the infarcted tissue. Specifically, the imaging studies showed that
the iron deposition began at the subendocardium but did not
extend beyond the mid wall. In addition, regression analysis
between the Scar Volume and Iron Volume showed a sigmoidal
relationship (R2= 0.75, p,0.001, Fig. 4), indicating that Iron
Volume is small when Scar Volume is small (,5%), rapidly
increasing at intermediate levels of scar (5–12%) and reaching
a plateau with any additional increases in Scar Volume.
Representative results from gross TTC staining and histological
staining for iron are shown in Fig. 5.
Surface ECG Recordings. To minimize the confounding
effects of Scar Volume on ECG parameters [37,38], in total 7 out
of the 10 animals that underwent surface ECG recordings (n = 3 in
Iron (,1.5%) and n= 4 in Iron (.1.5%)) were studied. The
animals with the extreme values of Scar Volume (i.e. on the
plateau regions of the sigmoidal response curve, Fig. 4) were not
included as part of the analysis. The mean Iron Volume of the two
groups were: 1.12%60.64% (Iron (,1.5%)) vs 2.47%60.64%
(Iron (.1.5%)), p = 0.02; and the mean Scar Volume of the two
groups were: 7.28%61.02% (Iron (,1.5%)) vs 8.35%62.98%
(Iron (.1.5%)), p = 0.51. Mean HR, QT, QTc, and QTcd values
obtained during day, night, and over 24 hours are shown in Fig. 6.
Mean hourly tracings of HR, QT, QTc, and QTcd over the 24-
hour period are shown in Fig. 7. QT, QTc and QTcd showed
statistically significant differences between Iron (,1.5%) and Iron
(.1.5%) groups. In particular, mean HR was not different
between Iron (.1.5%) and Iron (,1.5%) groups during the day
(77.9617.0 beats/min vs 78.1617.1 beats/min, p = 0.51), night
(88.767.4 beats/min vs 86.9613.4 beats/min, p= 0.73), or 24-
hour period (83.3614.0 beats/min vs 82.6615.8 beats/min,
p = 0.72). Mean QT was significantly different between Iron
(.1.5%) and Iron (,1.5%) during the day (263.067.2 ms vs
255.969.17 ms, p,0.001), night (278.8610.9 ms vs
265.969.3 ms, p,0.001), and 24-hour period (270.9612.1 ms
vs 260.9610.4 ms, p,0.001). Similarly, mean QTc was signifi-
cantly different between Iron (.1.5%) and Iron (,1.5%) during
the day (321.867.1 ms vs 308.9613.1 ms, p,0.001), night
(302.369.5 ms vs 289.1612.8 ms, p,0.001), and 24-hour period
(312.0612.9 ms vs 298.9616.1 ms, p,0.001). In addition, mean
QTcd was also significantly different between Iron (.1.5%) and
Iron (,1.5%) during the day (92.4625.8 ms vs 114.969.17 ms,
p,0.01), night (100.4635.0 ms vs 115.4625.3 ms, p = 0.04), and
24-hour period (96.4630.3 ms vs 115.1623.5 ms, p,0.001).
Electroanatomical Mapping Measurements. Of the 5
animals that underwent EAMs, one animal died during the
mapping procedure from spontaneous and sustained ventricular
tachycardia, despite cardioversion efforts. Regression analysis of
the scar size and location performed between CMR and EAM
were highly correlated (R2 = 0.77, p,0.05), indicating that the
registration between the two imaging modalities was significant.
Averaged across all animals, 770562212 electrograms (EGMs)
were recorded and 15776982 EGMs were manually validated on
each map in and around the scar. A representative set of EAMs
(bipolar voltage, bipolar activation and ILP maps) co-registered
with CMR (LGE and T2*) is shown in Fig. 8. On average, a total
of 158679 ILPs were observed in each dog, and 99658 of them
were co-registered with scar regions containing iron and 59628
were from scar regions without iron. The overall mean incidence
of ILPs in scar regions containing iron was greater than that from
regions without iron (Fig. 9A), but did not reach statistical
significance (p= 0.21). Similarly, the mean number of ILPs from
regions containing iron, normalized by the percentage of scar
volume containing iron, was larger than the mean number of ILPs
from regions not containing iron, normalized by percentage of scar
volume without iron; and the same observation was made for the
mean number of total ILPs normalized by total scar volume
(Fig. 9B). However these metrics also did not reach statistical
significance (p = 0.12).
Discussion
In this work, we investigated the effect of chronic iron
deposition within infarcted myocardium on the electrical behavior
of the heart. From ex-vivo electrical measurements in canine
myocardium, we showed that one of the consequences of chronic
iron deposition within the infarcted zones is the elevation in
electrical permittivity (e) of the infarcted myocardium, which is
commensurate with the extent of iron deposition. The bulk
electrical measurements also showed that the iron deposition
within the infarcted tissue leads to an elevation in electrical
permittivity, without a concomitant change in electrical conduc-
tivity (s). From surface ECG recordings of animals with different
Iron Volume but similar Scar Volume, we found that QT and QTc
interval were consistently longer in Iron (.1.5%) group compared
to Iron (,1.5%) during the 24-hour period, day, and night; but
QTcd was reduced during day, night and the 24-hour period in
Iron (.1.5%) group compared to Iron (,1.5%) group. Ultra-high
resolution LV endocardial EAMs, co-registered with CMR
images, showed a greater incidence of ILPs in regions of scar
with iron accumulation than those without iron accumulation.
Moreover, there was a tendency for the mean number of ILPs
observed per unit volume of scar with iron to be greater than those
observed per unit volume of scar without iron or total scar burden.
Biogenic magnetite (hemosiderin) is known to have the highest
electrical conductivity of any cellular material [39]. Thus, based
on previous reports on composite material properties [19], we
expected to find that scar tissue with iron deposits to have a greater
e compared to scar tissue without iron (a dielectric). Since the
observed changes in e were not accompanied by changes in s, it
appears that the effect of iron deposition is to transform the
infarcted territory into a capacitor [40]. Currently it is unclear how
these alterations in electrical tissue properties mediate the observed
changes in surface ECG parameters and EAMs. We anticipate
that theoretical modeling may provide mechanistic insight into
how or whether these tissue-specific electrical changes mediate
alterations in electrical activity in-vivo. Such models need to take
into account that the iron deposits following MI are found in the
interstitial space and that measurements of e and s that are
reported here were collected in ex-vivo preparations. Moreover,
since iron has been known to induce an inflammatory burden on
the surrounding myocardium [23], factors other than changes in e
may also explain the electrical changes observed in vivo.
Additional studies are needed to explore the mechanism by which
iron mediates electrical anomalies in vivo.
We observed the rise in the heart rate during the early morning
hours was slower in Iron (.1.5%) dogs than in Iron (,1.5%) dogs
(Fig. 7A). In addition, we also found marked prolongation in QT
and QTc among Iron (.1.5%) dogs hearts during the day, night
and 24 hours compared to Iron (,1.5%) dogs. These differences
may be examined in the context of previous studies that attempted
to discriminate between sudden cardiac death (SCD) victims and
MI survivors in the post infarction period. First, the slow rate of
increase in heart rate in SCD victims compared to MI survivors
has been reported in the waking hours [41]. Second, marked
changes in QTc patterns between SCD victims and MI survivors
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have also been reported. In fact, prolongation in QTc has been
strongly associated with SCD [42]. These collective observations
suggest that hearts with significant iron deposition (Iron(.1.5%))
may be more susceptible to arrhythmias than hearts with minimal
or no iron (Iron (,1.5%)).
ILPs have been shown to be substrates for ventricular
arrhythmias in the post infarction phase [43–45]. In particular,
ILPs are known to emerge from border zones and within the dense
scar [46,47]. The source of such ILPs has been associated with
surviving myocardial bundles within the infarct region, but
whether these bundles are indeed the only source of arrhythmias
is unclear. In this study, based on CMR and EAM, we
demonstrated that dense scar regions with iron deposits have a
greater prevalence of ILPs than scarred regions without iron. In
addition, this study showed that the number of ILPs per
percentage volume of substrate (total scar, scar without iron and
scar with iron) is greatest when the substrate is scar with iron. The
mechanistic underpinnings contributing to the association between
iron accumulations and ILPs in dense scar is not clear. While we
speculate that changes in electrical capacitance may explain the
isolated potential in the repolarization phase of the cardiac cycle,
further studies are necessary to understand how the iron deposits
couple with the endogenous electrical activity of the heart to
mediate the observed electrical anomalies.
Finally, recent studies [37,38,48–50] have shown that although
infarct volume is a predictor of arrhythmias, the incidence of
arrhythmias measured as percentage of arrhythmia-related deaths
or implantable cardio-defibrillator (ICD) discharge, plateaus
beyond a particular scar volume. Specifically, these studies have
shown that the incidence of arrhythmias at a Scar Volume of less
than 5% to be small, increasing rapidly between 5–10% and then
plateauing above 10%. Importantly, these studies showed that the
risk of developing arrhythmias increases from 10% (for scar
volume ,5%) to approximately 40–50% (for scar volume 5–10%).
Our analysis showed that for animals within this domain (i.e, 5%
, scar volume ,10%), it is possible to resolve two groups of dogs
with similar scar volumes but with markedly different iron
volumes. In fact, our study showed that when animals are
dichotomized on the basis of iron volume within this range of scar
volumes, the critical ECG parameters of repolarization in animals
with markedly higher iron content showed significant prolongation
of QT and QTc, as well as shortening of QTcd. Notably, such
directional changes, particularly in QTc, have been previously
associated with increased risk of ventricular arrhythmias in
humans [41,42]. In addition, it is has been shown that
arrhythmogenic substrate is typically found between the sub-
endocardium and the mid-wall [51,52], an observation that is
consistent with the spatial distribution of iron deposits in the
chronic infarction. These observations suggest that the extent of
iron deposition may be a better predictor of arrhythmias.
However, further studies are necessary to translate our findings
to the clinical arena.
Collectively taken, our findings from these studies showed that
the electrical behavior of infarcts with iron is different from infarcts
without iron. These observations point to the plausibility that iron
within myocardial scar may serve as a substrate for ventricular
arrhythmias in the chronic phase of the infarction period.
Additional studies are warranted to understand the mechanism
by which iron can potentially mediate arrhythmias. In this respect,
it would be of significant interest to understand whether and/or
how the iron deposits within the infarcted zones can electrically
interact with the surrounding healthy myocardium.
Limitations
This is the first study to evaluate the effects of iron in the post-
infarction scar using ex-vivo measurements, surface ECG record-
ings and EAM. However, this study has some limitations. First,
given the lack of a better method, electrical measurements of the
tissue samples isolated from the same slice were weight averaged in
order to examine relationships between e and s with iron. Implicit
in these estimated relationships are that the iron is uniformly
deposited within IRON+ infarcts, which may not be accurate. To
what extent the heterogeneity of iron deposition affects the local
electrical measures remains to be investigated. Topographic
current density images of infarcted tissues would be ideally suited
to such an investigation. However, the standard conductive atomic
force microscopy (C-AFM) typically used for generating current
density maps in spatially extended media has practical limitations
for use with fragile biological tissues such as the myocardium.
Moreover, measurements of e and s in tissue with and without
iron were made from ex-vivo sections, which only account for the
extracellular characteristics. Further studies are needed to address
the in-vivo effect of iron burden on electrical impedance. Third,
this study did not explore mechanistic insight into how the iron
deposition in the post infarction period mediates electrical
anomalies. Additional studies are needed to explore this limitation.
Fourth, the surface ECG recordings were limited to a 24-hour
period but longer recordings have the potential to further confirm
our 24-hour observations. In addition, while the metrics used to
evaluate the mean difference in the overall incidence of ILPs and
ILP count relative to substrate burden tended to be greatly
influenced by the presence and extent of iron deposits, they did not
reach statistical significance, likely because of small sample size.
Studies with larger sample size may establish statistical signifi-
cance. Finally, while this study demonstrated the possibility that
iron depositions in the chronic infarction induce electrical
anomalies in dogs, its effect on the electrical behavior in humans
following myocardial infarction remains to be investigated.
However, if these findings can be extended to humans, iron may
evolve as a novel arrhythmogenic substrate and T2* CMR can be
used to noninvasively guide appropriate patient selection for ICD
placements.
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